MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Using whole genome sequencing and intronic sequence analysis to identify pathogenic variants in Parkin-related Parkinson’s Disease

    R. Davis, K. Kumar, F. Edema-Hildebrand, J-S. Park, B. Koentjoro, V. Gayevskiy, M. Cowley, N. Blair, C. Sue (St Leonards, Australia)

    Objective: To clarify the genetic cause of autosomal recessive early-onset Parkinson’s Disease (EOPD) for which only a single heterozygous coding mutation could be identified. Background:…
  • 2019 International Congress

    Longitudinal DNA methylation changes, in blood, associated with Parkinson’s disease progression

    A. Henderson, K. Fisch, J. Hua, E. Driver-Dunckley, C. Sherzer, P. Desplats, T. Dunckley (Tempe, AZ, USA)

    Objective: To determine if whole blood DNA methylation profiles could distinguish Parkinson's disease from controls and whether any changes correlate with disease progression. Background: Parkinson’s…
  • 2019 International Congress

    The role of LRP10 mutations in Parkinson’s Disease and Dementia with Lewy Bodies

    A. Manini, E. Monfrini, L. Straniero, M. Vizziello, G. Franco, S. Duga, A. Di Fonzo (Milan, Italy)

    Objective: To test LRP10 in a cohort of Italian patients, with a clinical diagnosis of either Parkinson’s Disease (PD) (n=316) or Dementia with Lewy Bodies…
  • 2019 International Congress

    Expression profiles from CD14+ monocytes in PD patients with GBA mutations

    G. Riboldi, E. Udine, E. Navarro, M. Parks, B. Henderson, K. Sharma, T. Sikder, M. Zhuang, J. Crary, S. Frucht, T. Raj (New York, NY, USA)

    Objective: To study the pathogenic mechanisms associated with mutations of the GBAgenes in Parkinson’s disease (PD). Background: Mutation of GBA(encoding for glucocerebrosidase, GCase) is one of…
  • 2019 International Congress

    Identification of genetic alterations and SNCA mutation in Parkinson’s disease patients of Coimbatore Population, India

    D. Venkatesan, B. Vellingiri (Coimbatore, India)

    Objective: The aim of the study is to analyze the genetic alterations in SNCA gene and dopamine transporter in 22 PD patients of Coimbatore population.…
  • 2019 International Congress

    Wislon disease: clinical specificities of the disease course under normal ceruloplasmin in the blood, a clinical case from Kyrgyzstan

    N. Chekeeva (Bishkek, Kyrgyzstan)

    Objective: Apparent clinical picture of Wilson's disease with normal blood ceruloplasmin levels in young patients with Wilson's disease. Background: Wilson's disease is a hereditary disease…
  • 2019 International Congress

    Dysphagia in Adults with Niemann-Pick Disease Type C

    C. Lewis, M. Walterfang, A. Vogel (Melbourne, Australia)

    Objective: We aimed to (1) characterise baseline swallow function in people with NPC and (2) evaluate the impact of Miglustat treatment on the swallowing process.…
  • 2019 International Congress

    X-chromosomal Dystonia-Parkinsonism: a systematic review of published and unpublished clinical data

    M. Pauly, M. Ruiz López, H. Madoev, R. Rosales, C. Diesta, R. Jamora, S. Petkovic, N. Brüggemann, A. Westenberger, C. Klein, A. Domingo (Lübeck, Germany)

    Objective: To summarize and curate all published clinical data on x-chromosomal dystonia-parkinsonism (XDP) patients; identify relevant researches working on XDP and contact them for additional…
  • 2019 International Congress

    TFEB-driven expression prevents neurodegeneration in a multiple system atrophy mouse model

    ML. Arotcarena, M. Bourdenx, N. Dutheil, ML. Thiolat, E. Doudnikoff, S. Dovero, A. Ballabio, PO. Fernagut, W. Meissner, E. Bezard, B. Dehay (Bordeaux, France)

    Objective: To explore the potential neuroprotective effects of overexpressing the transcription factor EB in a MSA mouse model . Background: Synucleinopathies are neurodegenerative diseases characterized…
  • 2019 International Congress

    Prevalence of Rem Behavior Disorder (RBD) in different motor subtypes of Parkinson`s Disease corroborated by Polisomnography

    O. Cardenas, A. Abundes, M. Rodríguez, A. Cervantes, V. Alatriste (Mexico City, Mexico)

    Objective: The objective is to compare the prevalence of RBD in the different motor subtypes of Parkinson`s disease (PD), using polysomnography as the gold standard.…
  • « Previous Page
  • 1
  • …
  • 96
  • 97
  • 98
  • 99
  • 100
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley